Elanco Research Development from 2010 to 2026

ELAN Stock  USD 26.32  0.13  0.50%   
Elanco Animal Research Development yearly trend continues to be very stable with very little volatility. Research Development is likely to drop to about 338.1 M. During the period from 2010 to 2026, Elanco Animal Research Development quarterly data regression pattern had sample variance of 1380.1 T and median of  291,000,000. View All Fundamentals
 
Research Development  
First Reported
2016-12-31
Previous Quarter
89 M
Current Value
93 M
Quarterly Volatility
33.5 M
 
Covid
 
Interest Hikes
Check Elanco Animal financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elanco Animal's main balance sheet or income statement drivers, such as Tax Provision of 181.1 M, Depreciation And Amortization of 537.1 M or Interest Expense of 162.1 M, as well as many indicators such as Price To Sales Ratio of 3.38, Dividend Yield of 0.0 or PTB Ratio of 1.71. Elanco financial statements analysis is a perfect complement when working with Elanco Animal Valuation or Volatility modules.
  
Build AI portfolio with Elanco Stock
Check out the analysis of Elanco Animal Correlation against competitors.
Evaluating Elanco Animal's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Elanco Animal Health's fundamental strength.

Latest Elanco Animal's Research Development Growth Pattern

Below is the plot of the Research Development of Elanco Animal Health over the last few years. It is Elanco Animal's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elanco Animal's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Elanco Research Development Regression Statistics

Arithmetic Mean304,371,765
Geometric Mean302,257,801
Coefficient Of Variation12.21
Mean Deviation31,002,076
Median291,000,000
Standard Deviation37,150,307
Sample Variance1380.1T
Range122.4M
R-Value0.64
Mean Square Error876.8T
R-Squared0.40
Significance0.01
Slope4,678,333
Total Sum of Squares22082.3T

Elanco Research Development History

2026338.1 M
2025368 M
2024344 M
2022321 M
2021369 M
2020327 M
2019270.1 M

About Elanco Animal Financial Statements

Elanco Animal investors utilize fundamental indicators, such as Research Development, to predict how Elanco Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development368 M338.1 M

Pair Trading with Elanco Animal

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Elanco Animal position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elanco Animal will appreciate offsetting losses from the drop in the long position's value.

Moving together with Elanco Stock

  0.73AMG Amgen IncPairCorr

Moving against Elanco Stock

  0.721P Aurora CannabisPairCorr
  0.65P52 NEWBURY PHARMACEUTICALSPairCorr
  0.46VRCA Verrica PharmaceuticalsPairCorr
  0.42WEED Canopy Growth CorpPairCorr
  0.35BSFA ANI Pharmaceuticals Earnings Call TodayPairCorr
The ability to find closely correlated positions to Elanco Animal could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elanco Animal when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elanco Animal - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elanco Animal Health to buy it.
The correlation of Elanco Animal is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Elanco Animal moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Elanco Animal Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Elanco Animal can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Elanco Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elanco Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elanco Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elanco Animal Health Stock:
Check out the analysis of Elanco Animal Correlation against competitors.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Will Pharmaceuticals sector continue expanding? Could Elanco diversify its offerings? Factors like these will boost the valuation of Elanco Animal. Projected growth potential of Elanco fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Elanco Animal data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
1.167
Earnings Share
0.07
Revenue Per Share
9.498
Quarterly Revenue Growth
0.122
Return On Assets
0.0125
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Elanco Animal's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Elanco Animal should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Elanco Animal's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.